Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial

Marazzi Giuseppe; Pelliccia Francesco; Campolongo Giuseppe; Cacciotti Luca; Massaro Rosalba; Poggi Sara; Tanzilli Alessandra; Di Iorio Martina; Volterrani Maurizio; Lainscak Mitja; Rosano Giuseppe M.

首页> 外文期刊>International Journal of Cardiology >Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial

【24h】

Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial

机译：大规模心血管风险降低三次抗高血压药物和他汀类药物与自由药物组合：一体化试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background: The ultimate goal of antihypertensive therapy is cardiovascular risk (CVR) reduction. The aim of this study was to compare the efficacy and safety of once-daily fixed combination (ODFC) versus free-drug combination (FDC) of 3antihypertensive agents and statin.

机译：背景：抗高血压治疗的最终目标是心血管风险（CVR）减少。本研究的目的是比较曾经每日固定组合（ODFC）的疗效和安全性与3Antihypervervess和他汀类药物的自由药物组合（FDC）。

著录项

来源
《International Journal of Cardiology》 |2016年第null期|共3页
作者
Marazzi Giuseppe; Pelliccia Francesco; Campolongo Giuseppe; Cacciotti Luca; Massaro Rosalba; Poggi Sara; Tanzilli Alessandra; Di Iorio Martina; Volterrani Maurizio; Lainscak Mitja; Rosano Giuseppe M.;
展开▼
作者单位

IRCCS San Raffaele Roma Rome Italy;

Sapienza Univ Rome Fac Med 1 Rome Italy;

IRCCS San Raffaele Roma Rome Italy;

Vannini Hosp Rome Italy;

IRCCS San Raffaele Roma Rome Italy;

Sapienza Univ Rome Fac Med 1 Rome Italy;

Sapienza Univ Rome Fac Med 1 Rome Italy;

Sapienza Univ Rome Fac Med 1 Rome Italy;

IRCCS San Raffaele Roma Rome Italy;

Gen Hosp Celje Celje Slovenia;

IRCCS San Raffaele Roma Rome Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Hypertension; Hypercholesterolemia; Cardiovascular risk; Combination therapy;

机译：高血压;高胆固醇血症;心血管风险;联合治疗;

相似文献

外文文献
中文文献
专利

1. Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial [J] . Marazzi Giuseppe, Pelliccia Francesco, Campolongo Giuseppe, International Journal of Cardiology . 2016,第Null期

机译：大规模心血管风险降低三次抗高血压药物和他汀类药物与自由药物组合：一体化试验
2. Comparison of effectiveness and safety of fixed-dose combinations of antihypertensive agents with the free-drug combination of its components when given separately in hypertensive patients: a meta-analysis of 32134 patients [J] . S Arshad, AK Gupta, NR Poulter Journal of human hypertension . 2008,第10期

机译：高血压患者固定剂量联合使用降压药与其成分的自由药物组合的有效性和安全性比较：荟萃分析32134名患者
3. Comparison of the Efficacy and Safety Profiles of Two Fixed-Dose Combinations of Antihypertensive Agents, Amlodipine/Benazepril Versus Valsartan/Hydrochlorothiazide, in Patients With Type 2 Diabetes Mellitus and Hypertension: A 16-Week, Multicenter, Randomized, Double-Blind, Noninferiority Study [J] . LeeI.-T., HungY.-J., ChenJ.-F., Clinical therapeutics . 2012,第8期

机译：两种固定剂量抗高血压药氨氯地平/贝那普利与缬沙坦/氢氯噻嗪对2型糖尿病和高血压患者的疗效和安全性比较：一项为期16周的多中心随机双盲非劣效性研究
4. Efficacy and Safety of Combination of Prescription Omega-3 (Omacor~R) Added to Stable Statin Therapy in Hypertriglyceridemic Subjects: The COMBOS Trial [C] . M.H. Davidson, H. Bays, E.A. Stein, International Congress on Coronary Artery Disease . 2007

机译：处方ω-3（Omacor〜R）组合的疗效和安全性在高钙化血症科目中添加到稳定的汀类药物治疗：Combos试验
5. Sample size determination for Emax model, equivalence/non-inferiority test and drug combination in fixed dose trials. [D] . Wang, Jie. 2008

机译：在固定剂量试验中确定Emax模型，等效性/非劣效性试验和药物组合的样本量。
6. Erratum. Benefits of LixiLan a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035 [O] . Julio Rosenstock, Ronnie Aronson, George Grunberger, 2017

机译：勘误表。 LixiLan（一种可滴定比例的固定剂量组合胰岛素甘精胰岛素和Lixisenatide相对于胰岛素Glargine和Lixisenatide单组分在口服药物控制不充分的情况下的益处）：LixiLan-O随机试验。 2016年糖尿病护理； 39：2026-2035
7. Compliance patterns of patients treated with 2 separate antihypertensive agents versus fixed-dose combination therapy [O] . R WANOVICH 2004

机译：用2个单独的抗高血压剂治疗的患者的依从性模式与固定剂量联合治疗

Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅